Loading…

Evaluation of bacteriophage therapy to control Clostridium difficile and toxin production in an in vitro human colon model system

Clostridium difficile is a leading cause of hospital-acquired diarrhoea and represents a major challenge for healthcare providers. Due to the decreasing efficacy and associated problems of antibiotic therapy there is a need for synergistic and alternative treatments. In this study we investigated th...

Full description

Saved in:
Bibliographic Details
Published in:Anaerobe 2013-08, Vol.22, p.25-30
Main Authors: Meader, Emma, Mayer, Melinda J., Steverding, Dietmar, Carding, Simon R., Narbad, Arjan
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Clostridium difficile is a leading cause of hospital-acquired diarrhoea and represents a major challenge for healthcare providers. Due to the decreasing efficacy and associated problems of antibiotic therapy there is a need for synergistic and alternative treatments. In this study we investigated the use of a specific bacteriophage, ΦCD27, in a human colon model of C. difficile infection. Our findings demonstrate a significant reduction in the burden of C. difficile cells and toxin production with phage treatment relative to an untreated control, with no detrimental effect on commensal bacterial populations. The results demonstrate the potential of phage therapy, and highlight the limitations of using phages that have lysogenic capacity. •The potential of phage to prevent Clostridium difficile infection has been studied in vitro.•Phage treatment reduced vegetative C. difficile cells in 2 of 3 experiments.•Phage treatment consistently reduced C. difficile toxin production.•Lysogenisation of the phage was demonstrated.•Commensal flora was not negatively affected by phage treatment.
ISSN:1075-9964
1095-8274
DOI:10.1016/j.anaerobe.2013.05.001